MedTrace Logo

Cohort Of DEafness-gene Screening

NCT06133946 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 35920

Last updated 2023-11-18

No results posted yet for this study

Summary

This study was based on a concurrent newborn genetic and hearing screening program in Nantong city. From January 2016 to December 2020, newborn infants were recruited and received combined screening for free, funded in part by the municipal government and research project foundations. The population-based longitudinal databank for all children with hearing loss in Nantong city commenced in January 2016 and maintained indefinite recruitment and ongoing follow-up.

Conditions

Interventions

GENETIC

Genetic screening test (Deafness gene variant detection array kit)

Infant participants were screened for fifteen variants in four genes (i.e., GJB2, SLC26A4, MT-RNR1 and GJB3).

Sponsors & Collaborators

  • Nantong Maternal and Child Health Care Hospital

    collaborator UNKNOWN

  • Affiliated Hospital of Nantong University

    lead OTHER

Eligibility

Min Age
3 Days
Max Age
1 Week
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2021-03-31
Completion
2028-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06133946 on ClinicalTrials.gov